Avita Medical | 1811094D - 现金及等价物



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 142.87M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


现金及等价物 更改 日
Accuray USD 41.29M 22.05M 2025-12
Celltrion KRW 49.87B 20.22B 2025-12
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Cochlear AUD 275.7M 107.4M 2025-06
CSL USD 2.16B 633M 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Mayne Pharma AUD 110.07M 838K 2024-06
Medical Developments International AUD 17.84M 219K 2025-06
Nanosonics AUD 161.29M 156.45M 2025-06
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pacific Edge NZD 29.26M 8.79M 2024-06
Paradigm Biopharmaceuticals AUD 16.82M 1M 2025-06
Pharma Mar EUR 48.86M 31.05M 2026-03
Polynovo AUD 29.21M 16.7M 2025-12
PYC Therapeutics AUD 153.05M 103.8M 2025-06
Qiagen NV USD 839M 516.58M 2025-12
Ramsay Health Care AUD 784.4M 443.3M 2025-06
ResMed USD 1.42B 33.22M 2025-12
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Telix Pharmaceuticals AUD 207.16M 503.19M 2025-06
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03